Surgery pp 1839-1860 | Cite as

Lung Transplantation

  • Christine L. Lau
  • G. Alexander Patterson
  • R. Duane Davis


The first successful human lung transplant was performed in 1983 by the Toronto Lung Transplant Group.1 More than two decades have passed since this landmark procedure, and in the interim over 17,000 lung transplants have been performed.2 Lung transplantation currently is the preferred treatment option for a variety of end-stage pulmonary diseases. Remarkable progress has occurred through refinement in technique and improved understanding of transplant immunology and microbiology. The 1-, 3-, 5-, and 10-year actuarial survival rates for all lung transplants are 74%, 58%, 47%, and 24%, respectively.2 Despite these improvements, donor shortages and chronic lung allograft rejection continue to plague the field and prevent it from reaching its full potential. Chronic rejection of the lung allograft is currently the major hurdle limiting long-term survival. To date, prevention of known risk factors and treatment strategies have not lessened the devastating toll this process has on lung transplant survival.


Acute Rejection Lung Transplant Superior Vena Cava Bronchiolitis Obliterans Bronchiolitis Obliterans Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Toronto Lung Transplantation Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986;314:1140–1145.Google Scholar
  2. 2.
    Trulock EP, Edwards LB, Taylor DO, et al. The Registry of the International Society for Heart and Lung Transplantation: 21 official adult lung and heart-lung transplant report—2004. J Heart Lung Transplant 2004;23:804–815.PubMedCrossRefGoogle Scholar
  3. 3.
    Hardy JD, Webb WR, Dalton ML, Walker GR. Lung homotrans-plantation in man. JAMA 1963;186:1065–1074.PubMedGoogle Scholar
  4. 4.
    Wildevuur CRH, Benfield JR. A review of 23 human lung transplantations by 20 surgeons. Ann Thorac Surg 1970;9:489–515.PubMedGoogle Scholar
  5. 5.
    Nelems W. Human lung transplantation. Chest 1980;78:569.PubMedCrossRefGoogle Scholar
  6. 6.
    Lima O, Cooper JD, Peters WJ, et al. Effects of methylprednisolone and azathioprine on bronchial healing following lung auto-transplantation. J Thorac Cardiovasc Surg 1981;82:211.PubMedGoogle Scholar
  7. 7.
    Lima O, Goldberg M, Peters WJ, et al. Bronchial omentopexy in canine lung transplantation. J Thorac Cardiovasc Surg 1982;83:418–421.PubMedGoogle Scholar
  8. 8.
    Patterson GA, Cooper JD, Goldman B, et al. Technique of successful clinical double-lung transplantation. Ann Thorac Surg 1988;45:626–632.PubMedGoogle Scholar
  9. 9.
    Dark JH, Patterson GA, Al-Jilaihawi AN, et al. Experimental en bloc double-lung transplantation. Ann Thorac Surg 1986;42:394–398.PubMedGoogle Scholar
  10. 10.
    Pasque MK, Cooper JD, Kaiser LR, et al. An improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg 1990;49:785–791.PubMedCrossRefGoogle Scholar
  11. 11.
    Maurer JR, Frost AE, Estenne M, et al. International guidelines for selection of lung transplant candidates. J Heart Lung Transplant 1998;17:703–709.PubMedGoogle Scholar
  12. 12.
    Hertz MI, Taylor DO, Trulock EP, et al. The Registry of the International Society for Heart and Lung Transplantation: 19th official report—2002. J Heart Lung Transplant 2002;21:950–970.PubMedCrossRefGoogle Scholar
  13. 13.
    Aris RM, Neuringer IP, Weiner MA, et al. Severe osteoporosis before and after lung transplantation. Chest 1996;109:1176–1183.PubMedCrossRefGoogle Scholar
  14. 14.
    Gray-Donald K, Gibbons L, Shapiro SH, et al. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:961–966.PubMedGoogle Scholar
  15. 15.
    Meyers BF, Patterson GA. Lung transplantation versus lung volume reduction as surgical therapy for emphysema. World J Surg 2001;25:238–243.PubMedCrossRefGoogle Scholar
  16. 16.
    Meyers BF, Yusen RD, Guthrie TJ, et al. Outcome of bilateral lung volume reduction in patients with emphysema potentially eligible for lung transplantation. J Thorac Cardiovasc Surg. 2001;122:10–17.PubMedCrossRefGoogle Scholar
  17. 17.
    Sundaresan S, Shiraishi Y, Trulock EP, et al. Single or bilateral lung transplantation for emphysema? J Thorac Cardiovasc Surg 1996;112:1485–1495.PubMedCrossRefGoogle Scholar
  18. 18.
    Weill D, Keshavjee S. Lung transplantation for emphysema: two lungs or one. J Heart Lung Transplant 2001;20:739–742.PubMedCrossRefGoogle Scholar
  19. 19.
    Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Single versus bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant 2001;20:935–941.PubMedCrossRefGoogle Scholar
  20. 20.
    Dodge JA, Morison S, Lewis PA, et al. Cystic fibrosis in the United Kingdom, 1968–1988: incidence, population, and survival. Paediatric Perinatal Epidemiol 1993;7:157–166.CrossRefGoogle Scholar
  21. 21.
    Liou TG, Adler FR, Cahill B, et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001;286:2683–2689.PubMedCrossRefGoogle Scholar
  22. 22.
    Chaparro C, Maurer J, Gutierrez C, et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001;163:43–48.PubMedGoogle Scholar
  23. 23.
    Aris RM, Routh JC, LiPuma JJ, et al. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001;164:2102–2106.PubMedGoogle Scholar
  24. 24.
    Hosenpud JD, Bennett LE, Keck BM, et al. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998;351:24–27.PubMedCrossRefGoogle Scholar
  25. 25.
    United Network of Organ Sharing. UNOS Policy Allocation of Thoracic Organs, Waiting Time Accrual for Lung Candidates With Idiopathic Pulmonary Fibrosis (IPF). Richmond, VA: UNOS; 1997.Google Scholar
  26. 26.
    Trulock EP. Recipient selection. Chest Surg Clin North Am 1993;3:1–18.Google Scholar
  27. 27.
    Meyers BF, Lynch JP, Trulock EP, et al. Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a 10-year institutional experience. J Thorac Cardiovasc Surg 2000;120:99–107.PubMedCrossRefGoogle Scholar
  28. 28.
    McLaughlin W, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998;338:273–277.PubMedCrossRefGoogle Scholar
  29. 29.
    De Meester J, Smits JM, Persijn GG, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001;20:518–524.PubMedCrossRefGoogle Scholar
  30. 30.
    Charman SC, Sharpies LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002;21:226–232.PubMedCrossRefGoogle Scholar
  31. 31.
    Waddell TK, Bennett L, Kennedy R, et al. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant 2002;21:731–737.PubMedCrossRefGoogle Scholar
  32. 32.
    Sundaresan S, Trachiotis GD, Aoe M, et al. Donor lung procurement: assessment and operative technique. Ann Thorac Surg 1993;56:1409–1413.PubMedCrossRefGoogle Scholar
  33. 33.
    Straznicka M, Follette DM, Eisner MD, et al. Aggressive management of lung donors classified as unacceptable: excellent recipient survival 1 year after transplantation. J Thorac Cardiovasc Surg 2002;124:250–258.PubMedCrossRefGoogle Scholar
  34. 34.
    Sundaresan S, Semenkovich J, Ochoa L, et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 1995;109:1075–1080.PubMedCrossRefGoogle Scholar
  35. 35.
    Lau CL, Guthrie TJ, Scavuzzo M, et al. Lobectomy to downsize donor lungs for use in small recipients. J Heart Lung Transplant 2003;22:S116–S117.CrossRefGoogle Scholar
  36. 36.
    Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998;17:423–429.PubMedGoogle Scholar
  37. 37.
    Cummings J, Houck J, Lichtenfeld D. Positive effect of aggressive resuscitative efforts on cadaver lung procurement. J Transplant Coord 1995;5:103–106.Google Scholar
  38. 38.
    Barbers RG. Cystic fibrosis: bilateral living lobar versus cadaveric lung transplantation. Am J Med Sci 1998;315:155–160.PubMedCrossRefGoogle Scholar
  39. 39.
    Starnes VA, Barr ML, Schenkel FA, et al. Experience with living-donor lobar transplantation for indications other than cystic fibrosis. The J Thorac Cardiovasc Surg 1997;114:917–922.CrossRefGoogle Scholar
  40. 40.
    Cohen RG, Barr ML, Schenkel FA, et al. Living-related donor lobectomy for bilateral lobar transplantation in patients with cystic fibrosis. Ann Thorac Surg 1994;57:1423–1428.PubMedCrossRefGoogle Scholar
  41. 41.
    Starnes VA, Woo MS, MacLaughlin EF, et al. Comparison of outcomes between living donor and cadaveric lung transplantation in children. Ann Thorac Surg 1999;68:2279–2283; discussion 2283–2284.PubMedCrossRefGoogle Scholar
  42. 42.
    Battafarano RJ, Anderson RC, Meyers BF, et al. Perioperative complications after living donor lobectomy. J Thorac Cardiovasc Surg 2000;120:909–915.PubMedCrossRefGoogle Scholar
  43. 43.
    Couetil JA, Tolan MJ, Loulmet DF, et al. Pulmonary bipartitioning and lobar transplantation: a new approach to donor organ shortage. J Thorac Cardiovasc Surg 1997;113:529–537.PubMedCrossRefGoogle Scholar
  44. 44.
    Artemiou O, Birsan T, Taghavi S, et al. Bilateral lobar transplantation with the split lung technique. J Thorac Cardiovasc Surg 1999;118:369–370.PubMedCrossRefGoogle Scholar
  45. 45.
    Steen S, Sjoberg T, Pierre L, et al. Transplantation of lungs from a non-heart-beating donor [comment]. Lancet 2001;357:825–829.PubMedCrossRefGoogle Scholar
  46. 46.
    Gaca JG, Lesher A, Aksoy O, et al. Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation. Transplantation 2002;73:1717–1723.PubMedCrossRefGoogle Scholar
  47. 47.
    Meyers BF, Sundaresan RS, Guthrie T, et al. Bilateral sequential lung transplantation without sternal division eliminates posttransplantation sternal complications. J Thorac Cardiovasc Surg 1998;117:358–364.Google Scholar
  48. 48.
    King-Biggs MB, Dunitz JM, Park SJ, et al. Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. Transplantation 2003;75:1437–1443.PubMedCrossRefGoogle Scholar
  49. 49.
    Palmer SM, Miralles AP, Lawrence CM, et al. Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study. Chest 1999;116:127–133.PubMedCrossRefGoogle Scholar
  50. 50.
    Garrity ER Jr, Villanueva J, Bhorade SM, et al. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation 2001;71:773–777.PubMedCrossRefGoogle Scholar
  51. 51.
    Brock MV, Borja MC, Ferber L, et al. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab. J Heart Lung Transplant 2001;20:1282–1290.PubMedCrossRefGoogle Scholar
  52. 52.
    Zamora MR. Controversies in lung transplantation: management of cytomegalovirus infections. J Heart Lung Transplant 2002;21:841–849.PubMedCrossRefGoogle Scholar
  53. 53.
    Ettinger NA, Bailey TC, Trulock EP, et al. Cytomegalovirus infection and pneumonitis. Impact after isolation lung transplantation. Am Rev Respir Dis 1993;147:1017–1023.PubMedGoogle Scholar
  54. 54.
    Guilinger RA, Paradis IL, Dauber JH, et al. The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients. Am J Respir Crit Care Med 1995;152:2037–2043.PubMedGoogle Scholar
  55. 55.
    Hopkins PM, Aboyoun CL, Chhajed PN, et al. Prospective analysis of 1235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant 2002;21:1062–1067.PubMedCrossRefGoogle Scholar
  56. 56.
    Trulock EP, Ettinger NA, Brunt EM, et al. The role of transbronchial lung biopsy in the treatment of lung transplant recipients: an analysis of 200 consecutive procedures. Chest 1992;102:1049–1054.PubMedCrossRefGoogle Scholar
  57. 57.
    Sibley RK. The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant 1993;12:308–324.PubMedGoogle Scholar
  58. 58.
    Boehler A, Vogt P, Zollinger A, et al. Prospective study of the value of transbronchial lung biopsy after lung transplantation. Eur Respir J 1996;9:658–662.PubMedCrossRefGoogle Scholar
  59. 59.
    Baz MA, Layish DT, Govert JA, et al. Diagnostic yield of bronchoscopies after isolated lung transplantation [comment]. Chest 1996;110:84–88.PubMedCrossRefGoogle Scholar
  60. 60.
    Yousem SA. Significance of clinically silent untreated mild acute cellular rejection in lung allograft recipients. Hum Pathol 1996;27:269–273.PubMedCrossRefGoogle Scholar
  61. 61.
    Valentine VG, Taylor DE, Dhillon GS, et al. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant 2002;21:319–326.PubMedCrossRefGoogle Scholar
  62. 62.
    Kesten S, Chamberlain D, Maurer J. Yield of surveillance transbronchial biopsies performed beyond two years after lung transplantation. J Heart Lung Transplant 1996;15:384–388.PubMedGoogle Scholar
  63. 63.
    Chaparro C, Maurer JR, Chamberlain DW, Todd TR. Role of open lung biopsy for diagnosis in lung transplant recipients: 10-year experience. Ann Thorac Surg 1995;59:928–932.PubMedCrossRefGoogle Scholar
  64. 64.
    Lau CL, Patterson GA, Scott M. Palmer J. Critical care aspects of lung transplantation. J Intensive Care Med 2004;19:83–104.PubMedCrossRefGoogle Scholar
  65. 65.
    Matsuzaki Y, Waddell TK, Puskas JD, et al. Amelioration of post-ischemic lung reperfusion injury by PGE1. Am Rev Respir Dis 1993;148:882–889.PubMedGoogle Scholar
  66. 66.
    Keshavjee S, Yamazaki F, Cardoso PF, et al. A method for safe 12-hour pulmonary preservation. J Thorac Cardiovasc Surg 1989;98:529–534.PubMedGoogle Scholar
  67. 67.
    Maccherini M, Keshavjee SH, Slutsky AS, et al. The effect of low-potassium-dextran versus Euro-Collins solution for preservation of isolated type II pneumocytes. Transplantation 1991;52:621–626.PubMedCrossRefGoogle Scholar
  68. 68.
    Fischer S, Matte-Martyn A, De Perrot M, et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg. 2001;121:594–596.PubMedCrossRefGoogle Scholar
  69. 69.
    Yamashita M, Schmid RA, Ando K, et al. Nitroprusside ameliorates lung allograft reperfusion injury. Ann Thorac Surg 1996;62:791–797.PubMedCrossRefGoogle Scholar
  70. 70.
    Fujino S, Nagahiro I, Triantafillou AN, et al. Inhaled nitric oxide at the time of harvest improves early lung allograft function. Ann Thorac Surg 1997;63:1383–1390.PubMedCrossRefGoogle Scholar
  71. 71.
    Halldorsson A, Kronon M, Allen BS, et al. Controlled reperfusion prevents pulmonary injury after 24-hours of lung preservation. Ann Thorac Surg 1998;66.Google Scholar
  72. 72.
    Halldorsson A, Kronon M, Allen BS, et al. Controlled reperfusion after lung ischemia: implications for improved function after lung transplantation. J Thorac Cardiovasc Surg 1998;115:415–425.PubMedCrossRefGoogle Scholar
  73. 73.
    Clark SC, Sudarshan C, Khanna R, et al. Controlled reperfusion and pentoxifylline modulates reperfusion injury after single lung transplantation. J Thorac Cardiovasc Surg 1998;115:1335–1341.PubMedCrossRefGoogle Scholar
  74. 74.
    Bhabra MS, Hopkinson DN, Shaw TE, et al. Controlled reperfusion protects lung grafts during a transient early increase in permeability. Ann Thorac Surg 1998;65:187–192.PubMedCrossRefGoogle Scholar
  75. 75.
    Halldorsson AO, Kronon MT, Allen BS, et al. Lowering reperfusion pressure reduces the injury after pulmonary ischemia. Ann Thorac Surg 2000;69:198–203.PubMedCrossRefGoogle Scholar
  76. 76.
    Clark SC, Sudarshan CD, Dark JH. Controlled perfusion of the transplanted lung [comment]. Ann Thorac Surg 2001;71:1755–1756.PubMedCrossRefGoogle Scholar
  77. 77.
    Fiser SM, Kron IL, Long SM, et al. Controlled perfusion decreases reperfusion injury after high-flow reperfusion. J Heart Lung Transplant 2002;21:687–691.PubMedCrossRefGoogle Scholar
  78. 78.
    Lick SD, Brown PS, Jr., Kurusz M, et al. Technique of controlled reperfusion of the transplanted lung in humans [comment]. Ann Thorac Surg 2000;69:910–912.PubMedCrossRefGoogle Scholar
  79. 79.
    Date H, Triantafillou A, Trulock E, et al. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996;111:913–919.PubMedCrossRefGoogle Scholar
  80. 80.
    Fiser SM, Cope JT, Kron IL, et al. Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation [erratum appears in J Thorac Cardiovasc Surg 2001;121:1136]. J Thorac Cardiovasc Surg 2001;121:981–982.PubMedCrossRefGoogle Scholar
  81. 81.
    Meyers BF, Sundt TM 3rd, Henry S, et al. Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation. J Thorac Cardiovasc Surg 2000;120:20–26.PubMedCrossRefGoogle Scholar
  82. 82.
    Chhajed PJ, Malouf MM, Tamm M, et al. Interventional bronchoscopy for the management of airway complications following lung transplantation. Chest 2001;120:1894–1899.PubMedCrossRefGoogle Scholar
  83. 83.
    Griffith BP, Hardesty RL, Armitage JM, et al. A decade of lung transplantation. Ann Surg 1993;218:310–320.PubMedCrossRefGoogle Scholar
  84. 84.
    Schafers HJ, Haydock DA, Cooper JD. The prevalence and management of bronchial anastomotic complications in lung transplantation. J Thorac Cardiovasc Surg 1991;101:1044–1052.PubMedGoogle Scholar
  85. 85.
    Shennib H, Massard G. Airway complications in lung transplantation. Ann Thorac Surg 1994;57:506–511.PubMedCrossRefGoogle Scholar
  86. 86.
    Date H, Trulock EP, Arcidi JM, et al. Improved airway healing after lung transplantation. An analysis of 348 bronchial anastomoses. J Thorac Cardiovasc Surg 1995;110:1424–1432; discussion 1432–1433.PubMedCrossRefGoogle Scholar
  87. 87.
    Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis 1991;144:552–556.PubMedGoogle Scholar
  88. 88.
    Nunley DR, Gal AA, Vega JD, et al. Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation. Chest 2002;122:1185–1191.PubMedCrossRefGoogle Scholar
  89. 89.
    Palmer SM, Perfect JR, Howell DN, et al. Candidal anastomotic infection in lung transplant recipients: successful treatment with a combination of systemic and inhaled antifungal agents. J Heart Lung Transplant 1998;17:1029–1033.PubMedGoogle Scholar
  90. 90.
    Hadjiliadis D, Howell DN, Davis RD, et al. Anastomotic infections in lung transplant recipients. Ann Transplant 2000;5:13–19.PubMedGoogle Scholar
  91. 91.
    de Hoyos A, Patterson GA, Maurer J. Pulmonary transplantation: early and late results. J Thorac Cardiovasc Surg 1992;103:295–306.PubMedGoogle Scholar
  92. 92.
    Frost AE, Jammal CT, Cagle PT. Hyperacute rejection following lung transplantation. Chest 1996;110:559–562.PubMedCrossRefGoogle Scholar
  93. 93.
    Bittner HB, Dunitz J, Hertz M, et al. Hyperacute rejection in single lung transplantation—case report of successful management by means of plasmapheresis and antithymocyte globulin treatment. Transplantation 2001;71:649–651.PubMedCrossRefGoogle Scholar
  94. 94.
    Choi JK, Kearns J, Palevsky HI, et al. Hyperacute rejection of a pulmonary allograft. Immediate clinical and pathologic findings. Am J Respir Crit Care Med 1999;160:1015–1018.PubMedGoogle Scholar
  95. 95.
    Saint Martin GA, Reddy VB, Garrity DR, et al. Humoral (antibody-mediated) rejection in lung transplantation. J Heart Lung Transplant 1996;15:1217–1222.PubMedGoogle Scholar
  96. 96.
    Lau CL, Palmer SM, Posther KE, et al. Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients. Ann Thorac Surg 2000;69:1520–1524.PubMedCrossRefGoogle Scholar
  97. 97.
    Magro CM, Deng A, Pope-Harman A, et al. Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. Transplantation 2002;74:1273–1280.PubMedCrossRefGoogle Scholar
  98. 98.
    Levine SM, Bryan CL. Bronchiolitis obliterans in lung transplant recipients. The “thorn in the side” of lung transplantation [comment]. Chest 1995;107:894–897.PubMedCrossRefGoogle Scholar
  99. 99.
    Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997;155:789–818.PubMedGoogle Scholar
  100. 100.
    De Hoyos A, Chamberlain D, Schvartzman R, et al. Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. Chest 1993;103:1813–1818.PubMedCrossRefGoogle Scholar
  101. 101.
    Trulock EP. Management of lung transplant rejection. Chest 1993;13:1566–1576.CrossRefGoogle Scholar
  102. 102.
    Yousem SA, Berry GJ, Brunt EM, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. J Heart Lung Transplant 1990;9:593–601.Google Scholar
  103. 103.
    Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: lung rejection study group. J Heart Lung Transplant 1996;15:1–15.PubMedGoogle Scholar
  104. 104.
    Keenan RJ, Konishi H, Kawai A, et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 1995;60:580–585.PubMedCrossRefGoogle Scholar
  105. 105.
    Treede H, Klepetko W, Reichenspurner H, et al. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. J Heart Lung Transplant 2001;20:511–517.PubMedCrossRefGoogle Scholar
  106. 106.
    Vitulo P, Oggionni T, Cascina A, et al. Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation. J Heart Lung Transplant 2002;21:435–439.PubMedCrossRefGoogle Scholar
  107. 107.
    Horning NR, Lynch JP, Sundaresan SR, et al. Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation. J Heart Lung Transplant 1998;17:761–767.PubMedGoogle Scholar
  108. 108.
    Palmer SM, Baz MA, Sanders L, et al. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection. Transplantation 2001;71:1772–1776.PubMedCrossRefGoogle Scholar
  109. 109.
    Corris PA, Glanville A, McNeil K, et al. One year analysis of an ongoing international randomized study of mycophenolate mofetil (MMF) versus azathioprine (AZA) in lung transplantation [abstract]. J Heart Lung Transplant 2001;20:149–150.CrossRefGoogle Scholar
  110. 110.
    Sollinger HW, Group USRTMMS. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995;60:225–232.PubMedCrossRefGoogle Scholar
  111. 111.
    Kahan BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune U.S. Study Group [comment]. Lancet 2000;356:194–202.PubMedCrossRefGoogle Scholar
  112. 112.
    Hong JC, Kahan BD. Sirolimus rescue therapy for refractory rejection in renal transplantation. Transplantation 2001;71:1579–1584.PubMedCrossRefGoogle Scholar
  113. 113.
    Williams JW, Mital D, Chong A, et al. Experiences with leflu-nomide in solid organ transplantation. Transplantation 2002;73:358–366.PubMedCrossRefGoogle Scholar
  114. 114.
    Snell GI, Lewey BJ, Chin W, et al. Rescue therapy: a role for sirolimus in lung and heart transplant recipients. Transpl Proc 2001;33:1084–1085.CrossRefGoogle Scholar
  115. 115.
    Aboyoun CL, Tamm M, Chhajed PN, et al. Diagnostic value of follow-up transbronchial lung biopsy after lung rejection. Am J Respir Crit Care Med 2001;164:460–463.PubMedGoogle Scholar
  116. 116.
    Sheenib H, Massard G, Reynaud M, Noirclerc MJ. Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation. J Heart Lung Transplant 1994;13:514–519.Google Scholar
  117. 117.
    Griffith BP, Hardesty RL, Armitage JM, et al. Acute rejection of lung allografts with various immunosuppressive protocols. Ann Thorac Surg 1992;54:846–851.PubMedCrossRefGoogle Scholar
  118. 118.
    Barlow CW, Moon MR, Green GR, et al. Rabbit antithymocyte globulin versus OKT3 induction therapy after heart-lung and lung transplantation: effect on survival, rejection, infection, and obliterative bronchiolitis. Transplant Int 2001;14:234–239.CrossRefGoogle Scholar
  119. 119.
    Iacono AT, Smaldone GC, Keenan RJ, et al. Dose-related reversal of acute lung rejection by aerosolized cyclosporine. Am J Respir Crit Care Med 1997;155:1690–1698.PubMedGoogle Scholar
  120. 120.
    Reams BD, Davis RD, Curl J, Palmer SM. Treatment of refractory acute rejection in a lung transplant recipient with campath 1H. Transplantation 2002;74:903–904.PubMedCrossRefGoogle Scholar
  121. 121.
    Cahill BC, O’Rourke MK, Strasburg KA, et al. Methotrexate for lung transplant recipients with steroid-resistant acute rejection. J Heart Lung Transplant 1996;15:1130–1137.PubMedGoogle Scholar
  122. 122.
    Andreu G, Achkar A, Couetil JP, et al. Extracorporeal photoche-motherapy treatment for acute lung rejection episode. J Heart Lung Transplant 1995;14:793.PubMedGoogle Scholar
  123. 123.
    Villanueva J, Bhorade SM, Robinson JA, et al. Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant 2000;5:44–47.PubMedGoogle Scholar
  124. 124.
    Valentine VG, Robbins RC, Wehner JH, et al. Total lymphoid irradiation for refractory acute rejection in heart-lung and lung allografts. Chest 1996;109:1184.PubMedCrossRefGoogle Scholar
  125. 125.
    Burke CM, Theodore J, Dawkins KD, et al. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart lung transplantation. Chest 1984;86:824–829.PubMedCrossRefGoogle Scholar
  126. 126.
    Chamberlain D, Maurer J, Chaparro C, Idolor L. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant 1994;13:963–971.PubMedGoogle Scholar
  127. 127.
    ISHLT, Cooper JD, Billingham M, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993;12:713–716.PubMedGoogle Scholar
  128. 128.
    Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297–310.PubMedCrossRefGoogle Scholar
  129. 129.
    Sharpies LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002;21:271–281.CrossRefGoogle Scholar
  130. 130.
    Jackson CH, Sharpies LD, McNeil K, et al. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? J Heart Lung Transplant 2002;21:658–666.PubMedCrossRefGoogle Scholar
  131. 131.
    Ross DJ, Lweis MI, Kramer M, et al. FK 506 “rescue” immunosuppression for obliterative bronchiolitis after lung transplantation. Chest 1997;112:1175–1179.PubMedCrossRefGoogle Scholar
  132. 132.
    Kesten S, Chaparro C, Scavuzzo M, et al. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. J Heart Lung Transplant 1997;16:905–912.PubMedGoogle Scholar
  133. 133.
    Revell MP, Lewis ME, Llewellyn-Jones CG, et al. Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation. J Heart Lung Transplant 2000;19:1219–1223.PubMedCrossRefGoogle Scholar
  134. 134.
    Sarahrudi K, Carretta A, Wisser W, et al. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation. Transplant Int 2002;15:24–28.CrossRefGoogle Scholar
  135. 135.
    Whyte RI, Rossi SJ, Mulligan MS, et al. Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation. Ann Thorac Surg 1997;64:945–949.PubMedCrossRefGoogle Scholar
  136. 136.
    Speich R, Boehler A, Thurnheer R, Weder W. Salvage therapy with mycophenolate mofetil for lung transplantation bronchiolitis obliterans: importance of dosage. Transplantation 1997;64:533–535.PubMedCrossRefGoogle Scholar
  137. 137.
    Verleden GM, Buyse B, Delcroix M, et al. Cyclophosphamide rescue therapy for chronic rejection after lung transplantation. J Heart Lung Transplant 1999;18:1139–1142.PubMedCrossRefGoogle Scholar
  138. 138.
    Date H, Lynch JP, Sundaresan S, et al. The impact of cytolytic therapy on bronchiolitis obliterans syndrome. J Heart Lung Transplant 1998;17:869–875.PubMedGoogle Scholar
  139. 139.
    Snell GI, Esmore DS, Williams TJ. Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation. Chest 1996;109:874–878.PubMedCrossRefGoogle Scholar
  140. 140.
    Kesten S, Rajagopalan N, Maurer J. Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation. Transplantation 1996;61:427–430.PubMedCrossRefGoogle Scholar
  141. 141.
    Dusmet M, Maurer J, Winston T, Kesten S. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 1996;15:948–954.PubMedGoogle Scholar
  142. 142.
    Speich R, Boehler A, Russi EW, et al. A case report of a double-blind, randomized trial of inhaled steroids in a patient with lung transplant bronchiolitis obliterans. Respiration 1997;64:375–380.PubMedCrossRefGoogle Scholar
  143. 143.
    Iacono AT, Keenan R, Duncan SR, et al. Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am J Respir Crit Care Med 1996;153:1451–1455.PubMedGoogle Scholar
  144. 144.
    Diamond DA, Michalski JM, Lynch JP, Trulock EP. Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation. Int J Radiat Oncol 1998;41:795–800.CrossRefGoogle Scholar
  145. 145.
    Slovis BS, Loyd JE, L. E. King J. Photopheresis for chronic rejection of lung allografts. N Engl J Med 1995;332:962.PubMedCrossRefGoogle Scholar
  146. 146.
    O’Hagan AR, Stillwell PC, Arroliga A, Koo A. Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation. Chest 1999;115:1459–1462.PubMedCrossRefGoogle Scholar
  147. 147.
    Palmer SM, Miralles AP, Howell DN, et al. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest 2000;118:1214–1217.PubMedCrossRefGoogle Scholar
  148. 148.
    Lau CL, Palmer SM, Howell DN, et al. Laparoscopic anti-reflux surgery in the lung transplant population. Surg Endosc 2002;16:1674–1678.PubMedCrossRefGoogle Scholar
  149. 149.
    Davis RD, Lau CL, Eubanks S, et al. Improved lung allograft function following fundoplication in lung transplant patients with GERD. J Thorac Cardiovasc Surg 2003;125:533–542.PubMedCrossRefGoogle Scholar
  150. 150.
    Starzl TE, Demetris AJ, M. T, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992;340:876–877.PubMedCrossRefGoogle Scholar
  151. 151.
    Pham SM, Rao AS, Zeevi A, et al. Effects of donor bone marrow infusion in clinical lung transplantation. Ann Thorac Surg 2000;69:345–350.PubMedCrossRefGoogle Scholar
  152. 152.
    Novick RJ, Stitt LW, Al-Kattan K, et al. Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Ann Thorac Surg 1998;65:227–234.PubMedCrossRefGoogle Scholar
  153. 153.
    Chaparro C, Kesten S. Infections in lung transplant recipients. Clin Chest Med 1997;18:339–351.PubMedCrossRefGoogle Scholar
  154. 154.
    Bassiri AG, Girgis RE, Theodore S. Actinomyces odontolyticus thoracopulmonary infections. Two cases in lung and heart-lung transplant recipients and review of the literature. Am J Respir Crit Care Med 1995;152:374–376.Google Scholar
  155. 155.
    Palmer SM, Alexander BD, Sanders LL, et al. Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients. Transplantation 2000;69:2360–2366.PubMedCrossRefGoogle Scholar
  156. 156.
    Gutierrez CA, Chaparro C, Drajden M, et al. Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin. Chest 1998;113:924–932.PubMedCrossRefGoogle Scholar
  157. 157.
    Kruger RM, Paranjothi S, MD GAS, et al. Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients. J Heart Lung Transplant 2003;22:754–763.PubMedCrossRefGoogle Scholar
  158. 158.
    Zedtwitz-Liebenstein K, Presterl E, Deviatko E, Graninger W. Acute renal failure in a lung transplant patient after therapy with cidofovir. Transplant Int 2001;14:445–446.CrossRefGoogle Scholar
  159. 159.
    Palmer SM Jr, Henshaw NG, Howell DN, et al. Community respiratory viral infection in adult lung transplant recipients [comment]. Chest 1998;113:944–950.PubMedCrossRefGoogle Scholar
  160. 160.
    Holt ND, Gould FK, Taylor CE, et al. Incidence and significance of noncytomegalovirus viral respiratory infection after adult lung transplantation. J Heart Lung Transplant 1997;16:416–419.PubMedGoogle Scholar
  161. 161.
    Matar LD, McAdams HP, Palmer SM, et al. Respiratory viral infections in lung transplant recipients: radiologic findings with clinical correlation. Radiology 1999;213:735–742.PubMedGoogle Scholar
  162. 162.
    Garantziotis S, Howell DN, McAdams HP, et al. Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome [comment]. Chest 2001;119:1277–1280.PubMedCrossRefGoogle Scholar
  163. 163.
    McCurdy LH, Milstone A, Dummer S. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin. J Heart Lung Transplant 2003;22:745–753.PubMedCrossRefGoogle Scholar
  164. 164.
    Blumberg EA, Albano C, Pruett T, et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996;22:295–302.PubMedGoogle Scholar
  165. 165.
    Wandstrat TL. Respiratory syncytial virus immune globulin intravenous. Ann Pharmacother 1997;31:83–88.PubMedGoogle Scholar
  166. 166.
    Zahradnik JM. Adenovirus pneumonia. Semin. Respir Infect 1987;2:104–111.PubMedGoogle Scholar
  167. 167.
    Jurado M, Navarro JM, Hernandez J, et al. Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin. Bone Marrow Transplant 1995;15:651–652.PubMedGoogle Scholar
  168. 168.
    McCarthy AJ, Bergin M, De Silva LM, Stevens M. Intravenous ribavirin therapy for disseminated adenovirus infection. Pediatr Infect Dis J 1995;14:1003–1004.PubMedCrossRefGoogle Scholar
  169. 169.
    Maslo C, Girard PM, Urban T, et al. Ribavirin therapy for adenovirus pneumonia in an AIDS patient. Am J Respir Crit Care Med 1997;156:1263–1264.PubMedGoogle Scholar
  170. 170.
    Shetty AK, Gans HA, So S, et al. Intravenous ribavirin therapy for adenovirus pneumonia. Pediatr Pulmonol 2000;29:69–73.PubMedCrossRefGoogle Scholar
  171. 171.
    Cox NJ, Subbarao K. Influenza. Lancet 1999;354:1277–1282.PubMedCrossRefGoogle Scholar
  172. 172.
    Anonymous. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group [comment] [erratum appears in Lancet 1999;353:504]. Lancet 1998;352:1877–1881.Google Scholar
  173. 173.
    Dengler TJ, Strnad N, Buhring I, et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 1998;66:1340–1347.PubMedCrossRefGoogle Scholar
  174. 174.
    Grossi P, Farina C, Fiocchi R, Dalla Gasperina D. Prevalence and outcome of invasive fungal infections in 1963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 2000;70:112–116.PubMedGoogle Scholar
  175. 175.
    Kanj SS, Weity-Wolf K, Madden J, et al. Fungal infections in lung and heart-lung transplant recipients. Report of nine cases and review of the literature. Medicine 1996;75:142–156.PubMedCrossRefGoogle Scholar
  176. 176.
    Mehrad B, Paciocco G, Martinez FJ, et al. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 2001;119:169–175.PubMedCrossRefGoogle Scholar
  177. 177.
    Westney GE, Kesten S, DeHoyos A, et al. Aspergillus infection in single and double lung transplant recipients. Transplantation 1996;61:915–919.PubMedCrossRefGoogle Scholar
  178. 178.
    Hadjiliadis D, Sporn TA, Perfect JR, et al. Outcome of lung transplantation in patients with mycetomas [comment]. Chest. 2002;121:128–134.PubMedCrossRefGoogle Scholar
  179. 179.
    Nunley DR, Ohori P, Grgurich WF, et al. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 1998;114:1321–1329.PubMedCrossRefGoogle Scholar
  180. 180.
    Husain S, McCurry K, Dauber J, et al. Nocardia infection in lung transplant recipients. J Heart Lung Transplant 2002;21:354–359.PubMedCrossRefGoogle Scholar
  181. 181.
    Palmer SM, Kanj SS, Davis RD, Tapson VF. A case of disseminated infection with Nocardia brasiliensis in a lung transplant recipient. Transplantation 1997;63:1189–1190.PubMedCrossRefGoogle Scholar
  182. 182.
    Raj R, Frost AE. Scedosporium apiospermum fungemia in a lung transplant recipient. Chest 2002;121:1714–1716.PubMedCrossRefGoogle Scholar
  183. 183.
    Calvo V, Borro JM, Morales P, et al. Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group. Chest 1999;115:1301–1304.PubMedCrossRefGoogle Scholar
  184. 184.
    Erjavec Z, Woolthuis GM, de Vries-Hospers HG, et al. Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients. Eur J Clin Microbiol Infect Dis 1997;16:364–368.PubMedCrossRefGoogle Scholar
  185. 185.
    Palmer SM, Drew RH, Whitehouse JD, et al. Safety of aerosolized amphotericin B lipid complex in lung transplant recipients. Transplantation 2001;72:545–548.PubMedCrossRefGoogle Scholar
  186. 186.
    Ramsey SD, Patrick DL, Lewis S, et al. Improvement in quality of life after lung transplantation: a preliminary study. J Heart Lung Transplant 1995;14:870–877.PubMedGoogle Scholar
  187. 187.
    Cohen L, Littlefield C, Kelly P, et al. Predictors of quality of life and adjustment after lung transplantation. Chest 1998;113:633–644.PubMedCrossRefGoogle Scholar
  188. 188.
    Limbos MM, Chan CK, Kesten S. Quality of life in female lung transplant candidates and recipients. Chest 1997;112:1165–1174.PubMedCrossRefGoogle Scholar
  189. 189.
    Gross CR, Raghu G. The cost of lung transplantation and the quality of life post-transplant. Clin Chest Med 1997;18:391–403.PubMedCrossRefGoogle Scholar
  190. 190.
    TenVergert EM, Essink-Bot M-L, Geertsma A, et al. The effect of lung transplantation on health-related quality of life. Chest 1998;113:358–364.PubMedCrossRefGoogle Scholar
  191. 191.
    Paris W, Diercks M, Bright J, et al. Return to work after lung transplantation. J Heart Lung Transplant 1998;17:430–436.PubMedGoogle Scholar
  192. 192.
    Anyanwu AC, McGuire A, Rogers CA, Murday AJ. An economic evaluation of lung transplantation [comment]. J Thorac Cardiovasc Surg 2002;123:411–418; discussion 418–420.PubMedCrossRefGoogle Scholar
  193. 193.
    Boucek MM, Edwards LB, Keck BM, et al. Registry for the International Society for Heart and Lung Transplantation: seventh official pediatric report—2004. J Heart Lung Transplant 2004;23:933–947.PubMedCrossRefGoogle Scholar
  194. 194.
    Huddleston CB, Bloch JB, Sweet SC, et al. Lung transplantation in children. Ann Surg 2002;236:270–276.PubMedCrossRefGoogle Scholar
  195. 195.
    Patterson GA, Cooper JD. Lung transplantation. In: Shields TW, ed. General Thoracic Surgery, Vol. 1. Baltimore: Williams and Wilkins; 1994:1074.Google Scholar
  196. 196.
    Davis RD, Pasque MK. Pulmonary transplantation. Ann Surg 1995;221:14–28.PubMedCrossRefGoogle Scholar
  197. 197.
    McCurry KR, Iacono AT, Dauber JH, et al. Lung and heart-lung transplantation at the University of Pittsburgh. Clin Transpl 1997;11:209–218.Google Scholar
  198. 198.
    Lau CL, Palmer SM, D’Amico TA, et al. Lung transplantation at Duke University Medical Center. Clin Transpl 1998;12:327–340.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Christine L. Lau
    • 1
  • G. Alexander Patterson
    • 2
    • 3
  • R. Duane Davis
    • 4
  1. 1.Division of Cardiothoracic Surgery, Department of SurgeryWashington University School of MedicineSt. LouisUSA
  2. 2.Department of SurgeryWashington University School of MedicineSt. LouisUSA
  3. 3.Division of Cardiothoracic Surgery, Department of General Thoracic SurgeryWashington University School of MedicineSt. LouisUSA
  4. 4.Division of Cardiothoracic Surgery, Department of SurgeryDuke University Medical CenterDurhamUSA

Personalised recommendations